GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 204 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2022. The put-call ratio across all filers is 1.05 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $24,262,000 | +501.4% | 356,270 | +182.1% | 23.36% | +212.0% |
| Q2 2022 | $4,034,000 | -7.8% | 126,270 | 0.0% | 7.49% | +1.1% |
| Q1 2022 | $4,374,000 | +18.3% | 126,270 | 0.0% | 7.41% | +97.1% |
| Q4 2021 | $3,696,000 | +14.9% | 126,270 | 0.0% | 3.76% | +70.7% |
| Q3 2021 | $3,217,000 | -27.3% | 126,270 | 0.0% | 2.20% | -8.2% |
| Q2 2021 | $4,422,000 | -14.1% | 126,270 | 0.0% | 2.40% | +5.4% |
| Q1 2021 | $5,146,000 | -5.9% | 126,270 | 0.0% | 2.28% | +5.7% |
| Q4 2020 | $5,469,000 | – | 126,270 | – | 2.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |